Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review

Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review

Immunotherapy begins to be widely used due to the increasing exploration and gratifying effects in multiple cancers. Chordoma, as a rare bone malignant tumor, often recurs and metastasizes after undergoing surgery and radiotherapy. Therefore, immunotherapy can be explored as an emerging, potentially...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Shujing Liang, Jingxian Yang, Yun Lin, Tong Li, Wenrong Zhao, Jun Zhao, Chunyan Dong
Materialtyp: Artikel
Språk:English
Publicerad: Frontiers Media S.A. 2021-07-01
Serie:Frontiers in Immunology
Ämnen:
chordoma
immune checkpoint inhibitor
PD-1 blockade
sintilimab
myocarditis
myasthenia gravis
Länkar:https://www.frontiersin.org/articles/10.3389/fimmu.2021.682262/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.682262/full

Liknande verk